Schwartz Jeffrey Lawrence
Insider CIK 1702957 · MRNS 10% owner · RPID Director, 10% owner · DRNA Director, 10% owner · ANNX 10% owner · APTX 10% owner · REPL 10% owner · SWTX Director, 10% owner · ARQT 10% owner · BLSA Chief Executive Officer, Director, 10% owner · KMTS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KMTS KESTRA MEDICAL TECHNOLOGIE | A Award | 2026-09-09 | 2026-09-10 | 7,217 | — | $0 | 14,236 | SEC↗ |
| KMTS KESTRA MEDICAL TECHNOLOGIE | A Award | 2026-09-09 | 2026-09-10 | 7,217 | — | — | 14,236 | SEC↗ |
| KMTS KESTRA MEDICAL TECHNOLOGIE | S Sale | 2026-09-08 | 2026-09-10 | 3,890 | $25.18 | $98.0K | 7,019 | SEC↗ |
| KMTS KESTRA MEDICAL TECHNOLOGIE | S Sale | 2026-09-08 | 2026-09-10 | 3,890 | $25.18 | $97.9K | 7,019 | SEC↗ |
| KMTS KESTRA MEDICAL TECHNOLOGIE | A Award | 2025-09-04 | 2025-09-08 | 10,909 | — | $0 | 10,909 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | A Award deriv | 2024-05-23 | 2024-05-28 | 28,650 | — | $0 | 28,650 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | A Award | 2024-05-23 | 2024-05-28 | 14,300 | — | $0 | 14,300 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 10,572 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | A Award deriv | 2023-05-04 | 2023-05-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2023-03-16 | 2023-03-20 | 1,750,000 | $28.50 | $49.88M | 3,081,307 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | A Award deriv | 2022-05-23 | 2022-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-05-19 | 2022-05-20 | 15,318 | — | $0 | 15,318 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-05-19 | 2022-05-20 | 4,818 | — | $0 | 5,924 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-08-10 | 2021-08-12 | 1,000,000 | $70.25 | $70.25M | 4,831,307 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-21 | 35,000,001 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-21 | 6,672,819 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion | 2021-07-19 | 2021-07-21 | 6,999,998 | — | $0 | 6,999,998 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | P Buy | 2021-07-19 | 2021-07-21 | 100,000 | $20.00 | $2.00M | 8,434,560 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion | 2021-07-19 | 2021-07-21 | 1,334,562 | — | $0 | 8,334,560 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | A Award deriv | 2021-07-14 | 2021-07-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-05-20 | 2021-05-24 | 6,998 | — | $0 | 6,998 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-05-20 | 2021-05-24 | 1,106 | — | $0 | 1,106 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-03-09 | 2021-03-11 | 1,450,000 | $71.50 | $103.67M | 5,831,307 | SEC↗ |
| BLSA BCLS Acquisition Corp. | A Award | 2020-10-26 | 2020-10-26 | 487,500 | $10.00 | $4.88M | 487,500 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2020-10-26 | 2020-10-27 | 3,333,333 | $3.00 | $10.00M | 8,891,758 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 22,222,221 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 2,812,543 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 400,000 | $17.00 | $6.80M | 3,241,628 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 319,243 | — | $0 | 2,841,628 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,522,385 | — | $0 | 2,522,385 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-05-20 | 2020-05-22 | 7,464 | — | $0 | 7,464 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 2,825,602 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 859,573 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 2,825,602 | — | $0 | 2,825,602 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-04 | 2020-02-06 | 294,117 | $17.00 | $5.00M | 3,979,292 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 859,573 | — | $0 | 3,685,175 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-11-19 | 2019-11-21 | 1,750,000 | $22.03 | $38.55M | 5,580,237 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 150,000 | $18.00 | $2.70M | 7,281,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 6,078,103 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 7,131,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-09-12 | 2019-09-16 | 29,983 | — | $0 | 29,983 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-05-29 | 2019-05-31 | 1,600,000 | $12.50 | $20.00M | 7,330,237 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-03-29 | 2019-09-16 | 6,931,142 | — | $0 | 1,053,204 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-03-29 | 2019-09-16 | 40,000,000 | — | $0 | 6,078,103 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-26 | 235,146 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | P Buy | 2018-07-24 | 2018-07-26 | 500,000 | $15.00 | $7.50M | 2,838,968 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion | 2018-07-24 | 2018-07-26 | 2,338,968 | — | $0 | 2,338,968 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-19 | 2017-12-19 | 94,771 | $7.62 | $722.2K | 4,032,682 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-19 | 2017-12-19 | 55,229 | $7.11 | $392.7K | 3,977,453 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2017-12-18 | 2017-12-19 | 250,000 | $3.19 | $797.5K | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2017-12-18 | 2017-12-19 | 285,000 | $7.00 | $2.00M | 285,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2017-12-18 | 2017-12-19 | 8,454,388 | — | $0 | 8,739,388 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award | 2017-12-18 | 2017-12-19 | 190,849 | — | $0 | 8,930,237 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-18 | 2017-12-19 | 300,000 | $7.50 | $2.25M | 4,127,453 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-15 | 2017-12-19 | 102,882 | $8.64 | $888.9K | 4,427,453 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2017-12-15 | 2017-12-19 | 719,665 | $8.02 | $5.77M | 4,530,335 | SEC↗ |